Key Record Dates Identifier: NCT02942264
Brief Title: TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

First Submitted : October 21, 2016
First Submitted that Met QC Criteria : October 21, 2016
First Posted : October 24, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 3, 2019
Last Update Posted : January 4, 2019